Amantadine hydrochloride vs Co-beneldopa (Benserazide/levodopa)
National NHS prescribing compared (Prescription Cost Analysis)
Co-beneldopa (Benserazide/levodopa) was dispensed 7.0× as often as Amantadine hydrochloride in May 2026 — 77,476 items versus 11,047 in England.
11,047items
Amantadine hydrochloride · May 2026
NHSBSA Prescription Cost Analysis
77,476items
Co-beneldopa (Benserazide/levodopa) · May 2026
NHSBSA Prescription Cost Analysis
Figure 1. Amantadine hydrochloride versus Co-beneldopa (Benserazide/levodopa): national items dispensed by month
▬ Amantadine hydrochloride · ╌ Co-beneldopa (Benserazide/levodopa)
Source: NHSBSA Prescription Cost Analysis, to May 2026
| Measure | Amantadine hydrochloride | Co-beneldopa (Benserazide/levodopa) |
|---|---|---|
| Items, May 2026 | 11,047 | 77,476 |
| Items, last 12 months | 135,837 | 948,791 |
| Net ingredient cost, May 2026 | £104,156 | £953,642 |
See the full profile for Amantadine hydrochloride or Co-beneldopa (Benserazide/levodopa).